ACUD-1 is under clinical development by Accuitis and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success rate (PTSR) indication ...
Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...
Rosacea is a common skin malady characterized ... in kids with Crohn's Disease A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease ...
Hormonal changes during menopause can lead to skin changes, increasing the likelihood of rosacea developing or worsening. The decline in estrogen levels during menopause can affect blood vessels ...
There are plenty of things that can cause facial redness—rosacea, eczema, a damaged skin barrier, flushing and inflammation, to name a few—but now there’s finally one product that can ease ...
Caroline Igo (she/her/hers) is a wellness editor and holds Sleep Science Coach and Stress Management certificates from the Spencer Institute. She received her bachelor's degree in creative writing ...
These pills are formulated to upgrade multiple elements of males’ sexual wellness, such as amplifying libido, bettering erectile function, and enhancing stamina. When it comes to male ...
Researchers believe that disruptions in the skin microbiome may be responsible in part for rosacea (Journal of Drugs in Dermatology, June 1, 2019). Possibly some of the inflammation is related to ...